Allergic Rhinitis
Conditions
Interventions
Sponsors
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria of allergic rhinitis or have previously been diagnosed with allergic rhinitis; 2. The average total nasal symptom score (TNSS) of 1 week before treatment was more than 4; 3. No other drugs (such as intranasal glucocorticoid nasal spray, antihistamines, decongestants and anticholinergic drugs) or surgical treatment (such as endoscopic pterygoid neurectomy, endoscopic cryoablation and inferior turbinectomy) in the past 6 months; 4. Patients who are able to correctly describe their wishes, voluntarily fill in the informed consent form and agree to participate in clinical trials.
Exclusion criteria
Exclusion criteria: 1. Patients with serious diseases of heart, liver, kidney and other important organs; 2. Patients complicating with other respiratory diseases, acute/chronic sinusitis and other diseases; 3. Patients with organic lesions or nasal surgery; 4. Patients known or suspected to be allergic to the drugs used in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total nasal symptom scale (TNSS); | — |
Secondary
| Measure | Time frame |
|---|---|
| visual analogue scale (VAS);Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ); | — |
Countries
China
Contacts
Public ContactYAN Zhanfeng
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Outcome results
None listed